Tanjina Akter

Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease

Galina S. Bogatkevich, Paul J. Nietert, Tanjina Akter et al. · Arthritis & Rheumatism · 2011 · 103 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18

Elizabeth R. Volkmann, Donald P. Tashkin, Masataka Kuwana et al. · Arthritis & Rheumatology · 2019 · 83 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Overexpression of c-Met and CD44v6 Receptors Contributes to Autocrine TGF-β1 Signaling in Interstitial Lung Disease

Shibnath Ghatak, Galina S. Bogatkevich, Ilia Atnelishvili et al. · Journal of Biological Chemistry · 2013 · 45 citations · Full text

Life Sciences, Cell Biology, Pathobiology +17

The PPAR<i>γ</i>Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects

Galina S. Bogatkevich, Kristin B. Highland, Tanjina Akter et al. · Pulmonary Medicine · 2011 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Thrombin Increases Lung Fibroblast Survival while Promoting Alveolar Epithelial Cell Apoptosis via the Endoplasmic Reticulum Stress Marker, CCAAT Enhancer–Binding Homologous Protein

Ilia Atanelishvili, Jun Liang, Tanjina Akter et al. · American Journal of Respiratory Cell and Molecular Biology · 2013 · 19 citations · Full text

Life Sciences, Cell Biology, Pathobiology +16